These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28943544)

  • 21. Neuroleptic malignant syndrome and serotonin syndrome in a female patient: a clinicopathologic case.
    Gómez-Esteban JC; Barcena J; Forcadas M; Somme J; Agundez M; Tijero B; Zarranz JJ
    Clin Neuropharmacol; 2009; 32(5):299-300. PubMed ID: 19820435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Movement disorder emergencies.
    Kipps CM; Fung VS; Grattan-Smith P; de Moore GM; Morris JG
    Mov Disord; 2005 Mar; 20(3):322-34. PubMed ID: 15584031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Movement disorders emergencies. Part 1: Hypokinetic disorders.
    Robottom BJ; Weiner WJ; Factor SA
    Arch Neurol; 2011 May; 68(5):567-72. PubMed ID: 21555633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conundrums in neurology: diagnosing serotonin syndrome - a meta-analysis of cases.
    Werneke U; Jamshidi F; Taylor DM; Ott M
    BMC Neurol; 2016 Jul; 16():97. PubMed ID: 27406219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin syndrome presenting as pulmonary edema.
    Shah ND; Jain AB
    Indian J Pharmacol; 2016; 48(1):93-5. PubMed ID: 26997733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia.
    Komatsu T; Nomura T; Takami H; Sakamoto S; Mizuno K; Sekii H; Hatta K; Sugita M
    Intern Med; 2016; 55(19):2893-2897. PubMed ID: 27725556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic malignant syndrome.
    Levenson JL
    Am J Psychiatry; 1985 Oct; 142(10):1137-45. PubMed ID: 2863986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatal serotonin syndrome: a systematic review of 56 cases in the literature.
    Prakash S; Rathore C; Rana K; Prakash A
    Clin Toxicol (Phila); 2021 Feb; 59(2):89-100. PubMed ID: 33196298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin syndrome presenting as febrile encephalopathy with CSF pleocytosis: a report of three cases.
    Prakash S; Makwana P; Rathore C; Dave A
    Neurol Sci; 2016 Sep; 37(9):1561-4. PubMed ID: 27325387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catatonia and neuroleptic malignant syndrome: two sides of a coin?
    Vancaester E; Santens P
    Acta Neurol Belg; 2007 Jun; 107(2):47-50. PubMed ID: 17710840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuroleptic malignant syndrome. Problems of differential diagnosis. Description of a clinical case].
    Musto P; Vinay P; Coalda M; Bono D; Vai G
    Minerva Anestesiol; 1992; 58(7-8):459-64. PubMed ID: 1508360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of serotonin syndrome in an intensive care unit: A prospective observational study.
    Prakash S; Rathore C; Rana K
    J Crit Care; 2021 Jun; 63():92-97. PubMed ID: 33621893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroleptic malignant syndrome without neuroleptics.
    Ong KC; Chew EL; Ong YY
    Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perspectives on experimental models of serotonin syndrome in zebrafish.
    Stewart AM; Cachat J; Gaikwad S; Robinson KS; Gebhardt M; Kalueff AV
    Neurochem Int; 2013 May; 62(6):893-902. PubMed ID: 23485557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is There a Characteristic Clinical Profile for Patients with Dementia and Sundown Syndrome?
    Angulo Sevilla D; Carreras Rodríguez MT; Heredia Rodríguez P; Fernández Sánchez M; Vivancos Mora JA; Gago-Veiga AB
    J Alzheimers Dis; 2018; 62(1):335-346. PubMed ID: 29439326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Malignant hyperthermia syndrome in the intensive care unit : Differential diagnosis and acute measures].
    Grander W
    Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):407-16. PubMed ID: 27272514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evaluation and management of patients with neuroleptic malignant syndrome.
    Bhanushali MJ; Tuite PJ
    Neurol Clin; 2004 May; 22(2):389-411. PubMed ID: 15062519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venlafaxine-associated serotonin syndrome causing severe rhabdomyolysis and acute renal failure in a patient with idiopathic Parkinson disease.
    Rajapakse S; Abeynaike L; Wickramarathne T
    J Clin Psychopharmacol; 2010 Oct; 30(5):620-2. PubMed ID: 20814334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin syndrome: early management with cyproheptadine.
    McDaniel WW
    Ann Pharmacother; 2001; 35(7-8):870-3. PubMed ID: 11485136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neuroleptic malignant syndrome--rare diagnosis with high mortality].
    Petersén A; Lundberg L
    Lakartidningen; 2009 Apr 28-May 12; 106(18-19):1273-6. PubMed ID: 19537499
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.